SCHRODER INVESTMENT MANAGEMENT GROUP
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1086619
London, X0
Position in SUPN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$17,116,470
+$8,015,102 QoQ
Shares Held
368,017
+109.0% QoQ
Ownership
0.633%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#35
of 331 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $225,719,959 across 11 Drug Manufacturers - Specialty & Generic names. SUPN ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,280,484 | $77,262,797 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
72,306 | $39,177,559 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
1,129,781 | $39,169,506 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
1,618,404 | $23,450,672 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
368,017 | $17,116,470 | |
| 6 | HCM |
HUTCHMED (China) Ltd
|
1,477,494 | $15,897,835 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
333,656 | $8,211,273 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
16,253 | $2,739,280 |
All Filings in SUPN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,116,470 | 368,017 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $9,101,368 | 176,076 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $9,440,117 | 189,942 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $8,413,539 | 266,927 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,825,470 | 269,480 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $10,799,437 | 298,657 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $16,066,960 | 515,297 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $13,591,594 | 508,097 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $12,200,498 | 357,681 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $15,684,698 | 541,973 | Shares | Sole | 2024-02-14 | |
| 2020-06-30 | $32,300 | 1,360 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $220,557 | 12,260 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||